Defining RASopathy

Area of Science:

• Medical Genetics
• Molecular Biology
• Biochemistry

Background:

• RASopathies are a group of genetic syndromes characterized by overlapping clinical features.
• These syndromes stem from germline pathogenic variants affecting the RAS/mitogen-activated protein kinase (RAS/MAPK) signaling pathway.
• The complexity of the RAS/MAPK pathway, including its numerous components, interactions, and phenotypic variability, necessitates a clear definition.

Purpose of the Study:

• To define the key principles for identifying and classifying RASopathy syndromes.
• To emphasize the underlying molecular mechanisms and clinical manifestations of RASopathies.
• To highlight the potential therapeutic implications of understanding RAS/MAPK pathway dysregulation.

Main Methods:

• Review and synthesis of existing literature on RASopathies and the RAS/MAPK pathway.
• Analysis of the genetic basis and pathogenetic mechanisms underlying these syndromes.
• Consideration of the phenotypic spectrum and clinical features associated with RAS/MAPK pathway variants.

Main Results:

• A RASopathy is defined as a clinical syndrome with shared phenotypic features caused by germline variants in the RAS/MAPK pathway.
• Multiple pathogenetic mechanisms converge to cause RAS/MAPK pathway activation or dysregulation in RASopathies.
• Dysfunctional RAS/MAPK pathway activation in RASopathies suggests potential amenability to pathway-modulating therapies.

Conclusions:

• A clear definition of RASopathies is crucial due to the complexity of the RAS/MAPK pathway.
• Understanding the shared molecular underpinnings of RASopathies is essential for diagnosis and management.
• The identification of RAS/MAPK pathway dysregulation opens avenues for targeted therapeutic interventions.